In conclusion, our study performed a systematic, pan-cancer analysis of CX3CL1, assessing the potential association between CX3CL1 expression and clinical outcomes, pathological stages, and immune cell infiltration in a wide range of cancer types. This evidence concerns the gene CX3CL1 and cancer.